Cargando…
Activation of Intestinal Mucosal Immunity in Tumor‐bearing Mice by Lactoferrin
We have previously demonstrated that oral administration of bovine lactoferrin (bLF) markedly increases CD4(+) and CD8(+) T cells and NK (asialoGM1(+)) cells in the blood of tumor‐bearing mice and enhances anti‐metastatic activity. In this paper, we document that oral administration of bLF and bLF‐h...
Autores principales: | Wang, Wen‐Ping, Iigo, Masaaki, Sato, Jun, Sekine, Kazunori, Adachi, Isamu, Tsuda, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926262/ https://www.ncbi.nlm.nih.gov/pubmed/11050473 http://dx.doi.org/10.1111/j.1349-7006.2000.tb00880.x |
Ejemplares similares
-
Prevention of carcinogenesis and cancer metastasis by bovine lactoferrin
por: Tsuda, Hiroyuki, et al.
Publicado: (2006) -
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine
por: Iigo, Masaaki, et al.
Publicado: (2014) -
Possible Chemopreventive Effects of Bovine Lactoferrin on Esophagus and Lung Carcinogenesis in the Rat
por: Ushida, Yoshihiko, et al.
Publicado: (1999) -
Down‐regulation of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline (MeIQx)‐induced CYP1A2 Expression Is Associated with Bovine Lactoferrin Inhibition of MeIQx‐induced Liver and Colon Carcinogenesis in Rats
por: Fujita, Ken‐ichi, et al.
Publicado: (2002) -
Lactoferrin Inhibits Hepatitis C Virus Viremia in Patients with Chronic Hepatitis C: A Pilot Study
por: Tanaka, Katsuaki, et al.
Publicado: (1999)